240 related articles for article (PubMed ID: 27649305)
1. In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013.
Maroun R; Maunoury F; Benjamin L; Nachbaur G; Durand-Zaleski I
PLoS One; 2016; 11(9):e0162864. PubMed ID: 27649305
[TBL] [Abstract][Full Text] [Related]
2. Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database.
Maroun R; Fleury L; Nachbaur G; Maunoury F; Vanhille JL; Durand-Zaleski I
Curr Med Res Opin; 2017 Oct; 33(10):1755-1762. PubMed ID: 28748721
[TBL] [Abstract][Full Text] [Related]
3. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
[TBL] [Abstract][Full Text] [Related]
4. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
[TBL] [Abstract][Full Text] [Related]
5. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
[TBL] [Abstract][Full Text] [Related]
6. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
Uhart M; Blein C; L'Azou M; Thomas L; Durand L
Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
Maravic M; Jouaneton B; Vainchtock A; Tochon V
Clin Exp Rheumatol; 2012; 30(2):222-7. PubMed ID: 22546070
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of adverse events in patients with metastatic renal cell carcinoma.
Hagiwara M; Borker R; Oster G
Clin Ther; 2013 Dec; 35(12):1955-1963.e2. PubMed ID: 24290735
[TBL] [Abstract][Full Text] [Related]
9. Hospital burden of pulmonary arterial hypertension in France.
Bergot E; De Leotoing L; Bendjenana H; Tournier C; Vainchtock A; Nachbaur G; Humbert M
PLoS One; 2019; 14(9):e0221211. PubMed ID: 31536491
[TBL] [Abstract][Full Text] [Related]
10. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France.
Blein C; Gavazzi G; Paccalin M; Baptiste C; Berrut G; Vainchtock A
BMC Infect Dis; 2015 Aug; 15():350. PubMed ID: 26286598
[TBL] [Abstract][Full Text] [Related]
11. Costs associated with hospitalization in HIV-positive patients in France.
de Léotoing L; Yazdanpanah Y; Finkielsztejn L; Chaize G; Vainchtock A; Nachbaur G; Aubin C; Bonnet F
AIDS; 2018 Sep; 32(14):2059-2066. PubMed ID: 29894390
[TBL] [Abstract][Full Text] [Related]
12. Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies.
Cholley T; Thiery-Vuillemin A; Limat S; Hugues M; Calcagno F; Mouillet G; Anota A; Nerich V
Clin Genitourin Cancer; 2019 Feb; 17(1):e227-e234. PubMed ID: 30502046
[TBL] [Abstract][Full Text] [Related]
13. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.
St Guily JL; Borget I; Vainchtock A; Rémy V; Takizawa C
Head Neck Oncol; 2010 Sep; 2():22. PubMed ID: 20809978
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
[TBL] [Abstract][Full Text] [Related]
16. Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era.
Marchioni M; Bandini M; Pompe RS; Tian Z; Martel T; Kapoor A; Cindolo L; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Int Urol Nephrol; 2017 Dec; 49(12):2143-2149. PubMed ID: 28932952
[TBL] [Abstract][Full Text] [Related]
17. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
Heng C; Rybarczyk-Vigouret MC; Michel B
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):144-51. PubMed ID: 25079654
[TBL] [Abstract][Full Text] [Related]
19. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.
Joshi SS; Handorf EA; Zibelman M; Plimack ER; Uzzo RG; Kutikov A; Smaldone MC; Geynisman DM
Eur Urol; 2018 Sep; 74(3):387-393. PubMed ID: 29880274
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
